Pfizer Newsroom

Riot Shares Jump 13% as Activist Starboard Takes Stake in Bitcoin-Miner

WSJDec 12 09:35 ET

Pfizer To Go Ex-Dividend On January 24th, 2025 With 0.43 USD Dividend Per Share

Moomoo News19:45 ET

Pfizer announced an increase in the quarterly dividend.

The American pharmaceutical giant Pfizer announced on Thursday that it will increase the quarterly dividend by 2.4%, from 42 cents per share to 43 cents. The new dividend amounts to $1.72 per year, implying an annual yield of approximately 6.8%. Pfizer's CEO Albert Bourla stated that the increase in dividend highlights the company's strong financial performance, execution capabilities, and commitment to returning capital to shareholders.

Global Market Broadcast18:25 ET

Pfizer Boost Quarter Dividend by 2.4% to 43c

WSJ17:39 ET

Express News | Pfizer Inc - Increases Quarterly Dividend to $0.43 per Share

Reuters17:25 ET

Press Release: Pfizer Declares First-Quarter 2025 Dividend

Dow Jones17:25 ET

Express News | Pfizer Declares First-Quarter 2025 Dividend

Reuters17:25 ET

Pfizer Options Spot-On: On December 12th, 172.12K Contracts Were Traded, With 3.65 Million Open Interest

Moomoo News16:30 ET

Thursday Ends in Index Declines | Wall Street Today

Kevin Travers16:29 ET

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

Benzinga13:13 ET

Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock

Kevin Travers11:21 ET

CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal

Zacks Dec 12 10:05 ET

Are Pfizer Inc.'s (NYSE:PFE) Mixed Financials Driving The Negative Sentiment?

Yahoo FinanceDec 12 09:00 ET

Pfizer Announces Results From PATINA Trial

TipRanksDec 12 08:20 ET

Express News | Pfizer Inc - Overall Survival Data Not yet Mature

ReutersDec 12 08:15 ET

Pfizer's IBRANCE in Combination With Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients With HR+, HER2+ Metastatic Breast Cancer

BusinesswireDec 12 08:15 ET

Express News | Pfizer’s Ibrance® in Combination With Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 Patina Study in Patients With Hr+, Her2+ Metastatic Breast Cancer

ReutersDec 12 08:15 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $28 to $33

Moomoo NewsDec 12 08:00 ET · Ratings

Today's Analyst Rating | Citi Cuts Its Price Target Cut on Johnson & Johnson to $175, Deutsche Bank Upgrades Coca-Cola to Buy

Moomoo NewsDec 12 08:00 ET · Ratings

Pfizer (PFE) Gets a Hold From J.P. Morgan

TipRanksDec 12 03:55 ET · Ratings